Cargando…
Targeting Liver X Receptors for the Treatment of Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) refers to a range of conditions in which excess lipids accumulate in the liver, possibly leading to serious hepatic manifestations such as steatohepatitis, fibrosis/cirrhosis and cancer. Despite its increasing prevalence and significant impact on liver disea...
Autores principales: | Kim, Hyejin, Park, Chaewon, Kim, Tae Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177243/ https://www.ncbi.nlm.nih.gov/pubmed/37174692 http://dx.doi.org/10.3390/cells12091292 |
Ejemplares similares
-
Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
por: Kim, Tae Hyun, et al.
Publicado: (2021) -
Effect of Bombyx mori on the Liver Protection of Non-Alcoholic Fatty Liver Disease Based on In Vitro and In Vivo Models
por: Park, Miey, et al.
Publicado: (2021) -
Non-Alcoholic Fatty Liver Disease: The Bile Acid-Activated Farnesoid X Receptor as an Emerging Treatment Target
por: Fuchs, Michael
Publicado: (2012) -
Non-alcoholic fatty liver disease and liver secretome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2022) -
Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
por: Park, Ji-Won, et al.
Publicado: (2021)